Hysterectomy Checkpoints Hysterectomy Checkpoints  Hysterectomy Alternatives Alternatives   Hysterectomy Options Hysterectomy Options  Pre Op Hysterectomy Pre-op  Post Op Hysterectomy Post-op   Hormones HRT Menopause   Sexual Dysfuntion Intimacy   Fitness Pelvic Floor  Fitness Fitness   GYN Cancer Cancer  Grief Grief    
 
 
 

Articles for Hysterectomy Patients
Hysterectomy Article Female Sexual Arousal Disorder (FSAD) Facts

From the Sexual Dysfunction after Hysterectomy Articles List
Related Articles
Options to Hysterectomy
Pre-Op Hysterectomy
Post-Op Hysterectomy
Hormone and Menopause
Intimacy after Hysterectomy
Fitness after Hysterectomy
GYN Cancer
Hysterectomy Stories
Ask A Doctor

Advertisement




Once seen as mostly a psychological issue, in recent years female sexual dysfunction (FSD) has been recognized as a wide spread problem with physiological aspects that are treatable. According to reported data, up to 43 percent of women in the United States experience some form of FSD. One of the most commonly reported types of FSD is female sexual arousal disorder (FSAD).

Female Sexual Arousal Disorder (FSAD)
  • FSAD is the persistent or recurrent inability to attain or maintain the lubrication-swelling response of sexual excitement until completion of sexual activity
  • Arousal disorder is characterized by a lack of vaginal lubrication; decreased clitoral and labial sensation; decreased clitoral and labial engorgement; or decreased sexual arousal and excitement
  • When these symptoms cause significant personal distress to the women affected, a diagnosis of FSAD is made
  • FSAD occurs despite adequate focus, intensity and duration of sexual stimulation

Prevalence of FSAD
  • FSAD is experienced by approximately 20 percent of adult women
  • Three-fourths of women with FSAD are surgically or naturally menopausal
  • Data from the National Health and Social Life Survey indicate:

    o One-third of women report a lack of sexual interest
    o Nearly one-fourth do not experience orgasm
    o Up to 20 percent report lubrication difficulties, while a similar percentage do not find sex pleasurable

Causes of FSAD
  • Surgical procedures such as a hysterectomy may affect changes in blood flow, which can cause a lack of sensitivity and sexual arousal
  • A hysterectomy, with or without oophorectomy (removal of ovaries), may also affect how a woman feels about herself sexually
  • The decrease in estrogen levels associated with menopause may make the vagina dry and thin, even causing it to shrink
  • Certain medications such as oral contraceptives, antihypertensives and antidepressants, may impact sexual function and libido; Women taking these drugs may report a decrease in arousal, increase in vaginal dryness and increase in difficulty reaching orgasm
  • Psychological factors such as depression, stress and relationship issues may cause or contribute to FSAD
  • Other causes include certain chronic diseases like diabetes, lifestyle choices such as cigarette smoking, and surgical trauma or nerve damage to the pubic area

Diagnosing FSAD
  • In order to diagnose FSAD a detailed patient history (sexual, medical, gynecologic and psychosocial) should be provided to a physician
  • The diagnosis of FSAD is based typically on physical examination and psychological interviews, which could help determine whether the problem is physical or psychological

Treatment
  • The U.S. Food and Drug Administration has not approved any drug therapies for treating arousal or desire disorders
  • Estrogen replacement therapy has resulted in some improved clitoral sensitivity, increased libido and less pain during intercourse, but it is not currently approved for this indication and may not be adequate therapy for treating arousal
  • Sex therapists and psychologists may assist in improving communication between partners to help improve the actual act of sex, including foreplay, intercourse and talking about sex
  • ALISTA™ made by VIVUS, Inc., is currently in Phase 3 clinical studies for the treatment of FSAD; Women who are interested in learning more about the ALISTA clinical studies are encouraged to call 1-866-4-ALISTA (1-866-425-4782) to learn more about participating in this important research.

This information was provided by VIVUS, Inc.







Doctor Directory Doctor Directory

Keita Sakon, M.D.
7190 S. Cimarron Rd.
Las Vegas NV 89135
702 870 3921
Michele Cowling, M.D.
303 Nicollet Blvd
Burnsville MN 55337
952.460.4000
Betty Gingold Acker, M.D.
2900 E. 29th St
Suite 300
Bryan TX 77802
979-776-5602
Theodore Vlachos, M.D.
3535 W 13 Mile Rd
Royal Oak MI 48073
248-551-1399
Iris Orbuch, M.D.
202 Spring Street 2nd Floor
New York NY 10012
212-343-3040
Vincenzo Sabella, M.D.
7950 Floyd Curl Dr. Ste. 600
San Antonio TX 78229
210-615-8585
John Lenihan, M.D.
314 ML King Jr. Way
Suite 104
Tacoma WA 98465
253-403-5432
Nonnie-Marie Estella, M.D.
295 Varnom Ave
Hanchette Bldg 3rd Floor
Lowell MA 01854
978-459-8300
Danielle J Jimenez-Flores, M.D.
4324 N McColl
McAllen TX 78504
956-630-0240


Hysterectomy News [Read More]
-- January Newsletter
Post Hysterectomy Fitness and Health is the theme of our January, 2012 newsletter at HysterSisters.com. Visit this link [More]...

Latest Blog Post: Keep Walking
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Helpful Links

All times are GMT -6. The time now is 07:01 AM.

HysterSisters.com is a patient support website and does not intend to take the place of the relationship between patient and personal physician.

Medical Advisory Team - Give Me a Second - Second Opinions are Good For Your Health

Peer Support Websites: IC-Network
Hyster Sisters® Copyright 1998-2011 All rights reserved.
Page generated in 0.84720492 seconds with 12 queries
HysterSisters Hysterectomy | TOS | Privacy | About | Contact | Help/FAQ | Advertise | Hysterectomy Products | Advertising Policy | Doctors | Twitter | Facebook | Videos| Press Room
 
toggle

Receive support and resources for your hysterectomy related needs:

Support Forums - Hysterectomy Checkpoints - and more!